Study of Safety and Effectiveness of Apidra in Combination With Basal Insulin in Patients With Type 1 and 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SCALE
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 25 Feb 2009 Actual patient numbers (188) added as reported by ClinicalTrials.gov.
- 16 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.